Elutia Stock (NASDAQ: ELUT) stock price, news, charts, stock research, profile.
Open | $3.272 |
Close | - |
Volume / Avg. | 4.403K / 14.854K |
Day Range | 3.010 - 3.390 |
52 Wk Range | 1.100 - 4.189 |
Market Cap | $75.972M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 0.24% |
Days to Cover | 2.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elutia (NASDAQ: ELUT) through any online brokerage.
Other companies in Elutia’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), Intensity Therapeutics (NASDAQ:INTS), T2 Biosystems (NASDAQ:TTOO) and Burning Rock Biotech (NASDAQ:BNR).
The latest price target for Elutia (NASDAQ: ELUT) was reported by Cantor Fitzgerald on Friday, May 10, 2024. The analyst firm set a price target for 5.00 expecting ELUT to rise to within 12 months (a possible 53.37% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Elutia (NASDAQ: ELUT) is $3.26 last updated Today at May 24, 2024 at 3:03 PM EDT.
There are no upcoming dividends for Elutia.
Elutia’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Elutia.
Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.